Does aspirin save lives in patients with COVID-19?
Open Access
- 16 October 2021
- Vol. 108 (2), 88-89
- https://doi.org/10.1136/heartjnl-2021-320255
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation RegistryHeart, 2021
- Surviving Covid-19 with Heparin?The New England Journal of Medicine, 2021
- Pre-hospital antiplatelet medication use on COVID-19 disease severityHeart & Lung, 2021
- COVID‐19 mortality in patients on anticoagulants and antiplatelet agentsBritish Journal of Haematology, 2020
- Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational studyPharmacological Research, 2020
- Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept studyPharmacological Research, 2020
- Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19Acta Pharmaceutica Sinica. B, 2020